Douglas Mitchell: Do Bad Bugs Have Off Switches? | GenomeWeb

Recommended by: Gene Robinson, University of Illinois at Urbana-Champaign

Outbreaks of deadly drug-resistant pathogens are becoming more commonplace as antibiotics are overused and their potency decays.

Doug Mitchell loves antibiotics, but he says there must be a better way to treat disease. The University of Illinois at Urbana-Champaign's Mitchell is trying to develop new targets to create drugs that do not kill pathogens, but disrupt their ability to produce toxins, all without affecting the beneficial microbes in the body.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.